Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/358646


Changing Role of Medicare and its Impact on Pharmaceutical Industry


Description:

Pharmaceutical Companies Need to Resourcefully Incorporate Medicare Law in their Business Strategies

Many healthcare industry segments including pharmacy benefit managers (PBM) and private insurance providers are likely to be affected by the Medicare Prescription Drug Law. They will have to draw on all their resourcefulness to incorporate features of this law into their current business strategy, as they have to alter and leverage regulatory points with each process. This could put added pressure on drug manufacturers to comply with new codes and necessitate review of their pricing procedures. Pharmaceutical companies are expected to face a threat from popularity of generic drugs and imminent patent expiration of several branded ones. All this will require a new business model that can create a ‘win-win’ scenario for all parties - including Medicare beneficiaries.

This strategic analysis service studies the changing role of Medicare and its impact on pharmaceutical companies besides examining the Medicare Prescription Drug Law. It also outlines the need for changes in business strategies to deal with the amendment in Medicare laws and provides the advantages of Medicare to beneficiaries, its influence on pharmaceuticals’ revenue, and the increase in Medicare spending.

Mandatory Cost Sharing Under the Medicare Law Helps Pharmaceutical Companies Sustain Profit Margins

With a rapidly growing senior population, there is a high need for life-saving drugs. Improvements in insurance coverage of prescription drugs for Medicare beneficiaries are expected to increase drug utilization in future. Medicare spending is likely to increase as more beneficiaries enroll in the program following the new prescription drug law, says the analyst. Medicare spending is estimated to rise from nearly $280.0 million in 2003 to more than $525.0 million in 2010.

Prescription drug coverage for Medicare beneficiaries is expected to be key in increasing Medicare enrollees, boosting Medicare spending. If this trend continues, it is projected to help pharmaceutical companies and other segments of the industry retain their profit margins. The financial situation of many companies hinges on the Medicare law and on how best it is incorporated in their business models.

Persistence with Drug Innovation despite Change in Medicare Law Helps Capture Market Segments

Price controls on drugs - prompted by the Medicare law - can impede innovation and this may deprive patients of access to breakthrough therapies or life-saving drugs. Pharmaceuticals companies that synchronize their business strategy with the new law and communicate the change appropriately are most likely to retain existing markets. By not using the Medicare law as an excuse to delay drug discovery, but by using it as a stimulant to innovation, pharmaceuticals companies can achieve greater market shares and revenue.

Pioneering better technologies can help companies obtain rebates from the government. Innovative breakthrough products for seniors in segments such as rheumatoid arthritis and Alzheimer's disease can save millions of dollars in prescription drugs, notes the analyst. Bringing innovative products to market can open new sectors and spur creation of completely new market segments.


Contents: 1. Changing Role of Medicare and its Impact on Pharmaceutical Industry

- 1. Overview

- - 1. Introduction

- - 2. Disclaimer

- - 3. Certification

- - 4. Research Scope and Methodology

- 2. Basics of Medicare

- - 1. Introduction   

- - 2. Medicare - The Basics

- - 3. Medicare Beneficiaries   

- - 4. Types of Medicare Plans   

- - 5. Types of Services to Medicare Beneficiaries

- 3. Issues with Medicare

- - 1. Introduction

- - 2. Issues with Medicare

- - 3. Why need Change?

- - 4. Why need change contd..

- - 5. CEO Quote

2. Medicare Prescription Drug Law and its Implications

- 1. Medicare Prescription Drug Law

- - 1. Introduction

- - 2. Points to Ponder to Modernize Medicare

- - 3. Challenges and Opportunity   

- - 4. Cost to Beneficiaries

- - 5. Key Features

- - 6. Benefits to Consumers

- 2. Impact on Different Segments of the Healthcare Industry

- - 1. Introduction

- - 2. Flowchart of Prescriptions

- - 3. Important Provisions of the Act

- - 4. Impact on Healthcare Industry Segments

- - 5. Impact on Employers

- - 6. Impact on Medicaid

- - 7. Impact on Pharmacy Benefits Managers

- - 8. Impact on Retail Pharmacies

- - 9. CEO Quote

3. Impact of Medicare Law on the Pharmaceutical Industry

- 1. Medicare Spending on Prescription Drugs

- - 1. Introduction

- - 2. Forecasts of Beneficiaries with Prescription Drug Benefits

- - 3. Analysis of Medicare Beneficiaries with Prescription Drug Benefits

- - 4. Medicare vs. Total Prescription Spending on Medicare Beneficiaries

- - 5. Analysis of Prescription Drug Spending on Medicare Beneficiaries - I

- - 6. Analysis of Prescription Drug Spending on Medicare Beneficiaries - II

- - 7. Direct Medicare Spending vs. Total Medicare Spending

- - 8. Analysis of Direct Prescription vs. Total Medicare Spending

- - 9. Implications of Prescription Drug Law

- - 10. CMS Administrator Quote

- 2. Business Planning and Strategic Thinking

- - 1. Introduction

- - 2. Achieving Sustained Value Growth

- - 3. Capturing Opportunity and Avoiding Strategic Risk

- - 4. Already Known to 2010 and Beyond

- - 5. Meeting the Challenge

- - 6. Complying with Medicare

- - 7. Strategic Thinking and Analysis

- - 8. Anticipating the Future

- - 9. CEO Quote

- 3. Perceived Impact on Pharmaceutical Revenues

- - 1. Introduction

- - 2. Market Expansion Opportunity

- - 3. Market Expansion

- - 4. Reaction to the Medicare Prescription Drug Law

- - 5. Implications on Pharmaceutical Industry

- - 6. Challenges for Pharmaceutical Companies

- - 7. CEO Quote

- - 8. Potential Impact on Revenues of Pharmaceutical Companies

- - 9. Affect on Pharmaceutical Revenues

- - 10. Critical Evaluation

- 4. Frost and Sullivan Awards

- - 1. Introduction

- - 2. Company of the Year Award

- - 3. Best Support and Services Award

- - 4. Client Value Enhancement Award

- - 5. Innovative Business Development Strategy Award

- 5. Decision Support Databases

- - 1. Medicare Expenditure

- - 2. Medicare Enrollment

- - 3. Population 65 and Above

- - 4. Private Health Insurance

- - 5. Healthcare Expenditure

- - 6. Uninsured Population

- 6. Frost and Sullivan

- - 1. Healthcare Team

- - 2. Our Capabilities

- - 3. Key Advantages

- - 4. Consulting Clients

- - 5. Growth Consulting

- - 6. Growth Consulting Deliverables

- - 7. Growth Partnership Services

- - 8. Growth Partnership Services Platform

- - 9. Growth Consulting Process




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/358646

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 24/11/2009 04:08:28
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Changing Role of Medicare and its Impact on Pharmaceutical Industry
Web Address:
http://www.researchandmarkets.com/reports/358646
Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License €3,324.00
Electronic (PDF) - Enterprisewide €4,332.00
Electronic and Hard Copy (PDF) - Enterprisewide €4,668.00 + EUR€ 50.00 Shipping/Handling *
Electronic and Hard Copy (PDF) - Site License €3,660.00 + EUR€ 50.00 Shipping/Handling *
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 24/11/2009 04:08:28

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)